Log In
person
BioMarin Pharmaceutical Inc
BMRN
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Rare Disease Therapies |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
2.37B | 98.07% |
| Rare Disease Therapies |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
0.05B | 1.93% |
| keyboard_arrow_down |
Rare Disease Therapies
Branded Pharmaceuticals
|
2.37B | 98.07% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Rare Disease Therapies
Pharmaceutical Patent Licensing
|
0.05B | 1.93% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||